Syngene International Limited has informed the Exchange regarding a press release dated December 01, 2023, titled "Syngene concludes the acquisition of biologics manufacturing facility from Stelis Biopharma Ltd".
Press Release Dec 01 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Syngene International Ltd. on 6ix
Earlier from Syngene International
- Press Release Oct 17 2023
- Press Release Jul 26 2023
- Press Release Jul 04 2023
- Press Release Apr 26 2023
- Press Release (Revised) Jan 23 2023
Later from Syngene International
- Press Release Jan 25 2024
- Press Release Apr 24 2024
- Press Release Jul 24 2024
- Press Release Oct 23 2024
- Press Release Jan 23 2025
Follow Syngene International into a list and get an email when it puts out news.
Follow Syngene International